The new production line is equipped with the latest advanced manufacturing system to produce quality products of Alkaloids & APIs used in a wide range of pharmaceutical applications
The pre-approval inspection of USFDA was completed successfully with ZERO 483 observation of the manufacturing facilities of Bajaj Healthcare Limited
BHL will undertake the development and supply of these molecules
The plant has a capacity for extraction of 2500 mt of poppy straw and 300 mt poppy gum per year
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
It is used to control, prevent and normalize the symptoms associated with Alzheimer's disease, attention disorder, bipolar disorder, Parkinson's disease among others
Acute therapies continue to report strong growth compared to chronic ones.
Marketed under the brand name DGJAJ, it helps in the faster recovery of hospitalised patients and reduces supplemental oxygen dependence
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)